Alexandra Ellervik
Investor Relations Contact at CHOSA ONCOLOGY AB
Profile
Alexandra Ellervik is currently the Head of Communication & Investor Relations at Chosa Oncology AB.
Previously, she worked as an Investor Relations & Press Contact at RhoVac AB.
Alexandra Ellervik active positions
| Companies | Position | Start |
|---|---|---|
| CHOSA ONCOLOGY AB | Investor Relations Contact | - |
Former positions of Alexandra Ellervik
| Companies | Position | End |
|---|---|---|
| CHOSA ONCOLOGY AB | Investor Relations Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CHOSA ONCOLOGY AB | Commercial Services |
| Private companies | 1 |
|---|---|
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology RhoVac AB opertaes as biotechnology company that engages in the research and development of immunotherapy. The firm develops therapeutic cancer vaccines. Its main focus is the development of a drug with the potential to prevent or limit the metastasis of metastatic cancers. The company was founded by Bo Anders Ljungqvist, Per Thor Straten, and Mads Hald Andersen in November 2015 and is headquartered in Lund, Sweden. | Health Technology |
- Stock Market
- Insiders
- Alexandra Ellervik
